Roche has announced a new 'open innovation' research alliance in nanotechnology to develop new diagnostic tools. The Swiss company is to work with BioMed X, a new open innovation lab in Heidelberg ...
“Solving the signal-to-noise challenge is a key efficiency driver for the technology,” said Mark Kokoris, head of SBX technology at Roche Diagnostics, and former co-founder and CEO of Stratos.
As a leading developer and producer of medical tests and digital tools, Roche Diagnostics’ North American headquarters in Indianapolis works in partnership with laboratories to provide the ...
Medical Device Network on MSN1d
Roche Diagnostics supports UK eye cancer AI initiativeRoche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...
Swiss pharmaceutical giant Roche operates across ... immunology and neurology. Its diagnostics division, which provides tests, instruments and digital tools for healthcare and medical researchers ...
The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out ...
F. Hoffmann-La Roche Ltd (Roche) is a healthcare company that develops drugs and diagnostics devices for treating diseases. It provides medicine and diagnostics for oncology, immunology ...
"One in eight women in the United States will face invasive breast cancer in their lifetime,” said Matt Sause, CEO of Roche Diagnostics. "The rising incidence of metastatic breast cancer, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback